TAYLOR ANDREW LAWRENCE (Chief Financial Officer) received a stock award from ORCHESTRA BIOMED HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2026ACC: 0001104659-26-015320
Officer· Chief Financial Officer
Since Feb 2026
+181K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
181K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+181K
Price / share
—
Trade value
—
% of position
40.1%
2/12/2026
451.49K→632.49K
Total
Net shares
+181K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 2/12/2026 | A · Award | +181K | — | — | 40.1% | 451.49K | 632.49K |
| Total | +181K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported